Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep1154 | Clinical Cases–Pituitary/Adrenal | ECE2015

A case report of Langerhan cells histiocytosis – the need for a good transition care

Balsa Ana Margarida , Bastos Margarida , Moreno Carolina , Guelho Daniela , Cardoso Luis , Vicente Nuno , Martins Diana , Oliveira Diana , Alves Marcia , Guimaraes Joana , Carrilho Francisco

Introduction: Langerhan Cells Histiocytosis (LCH) is a rare heterogeneous idiopathic clinical entity involving clonal proliferation of Langerhan cells that may infiltrate most commonly bone, skin, lymph nodes or lungs. It affects mainly children between 5 and 15 years. The most common endocrine manifestation is diabetes insipida.Clinical case: The authors describe a case of a 19-year-old female patient, admitted in the Transition Follow-up of the Endocri...

ea0037ep509 | Diabetes (complications & therapy) | ECE2015

Diabetes mellitus and chronic kidney disease: two decades of consultation of diabetes and kidney transplant, a retrospective study

Balsa Ana Margarida , Bastos Margarida , Dantas Rosa , Batista Carla , Alves Rui , Roseiro Antonio , Moreno Carolina , Guelho Daniela , Cardoso Luis , Vicente Nuno , Martins Diana , Oliveira Diana , Alves Marcia , Guimaraes Joana , Mota Alfredo , Carrilho Francisco

Introduction: Diabetic nephropathy is the main global cause of end stage renal disease. According to the annual report from the Portuguese National Diabetes Observatory, in 2013, the prevalence of diabetes mellitus (DM) in new cases of chronic kidney disease was 31.2 and 11.1% in kidney transplant patients.Aim: To characterise the population of type 2 diabetic patients admitted in diabetes and kidney transplant consult (DKTC), comparing those admitted be...

ea0056p124 | Endocrine tumours and neoplasia | ECE2018

Genetic background as a predictive factor of pheochromocytoma and paraganglioma presentation

Lages Adriana De Sousa , Paiva Isabel , Cardoso Luis , Oliveira Patricia , Rodrigues Dircea , Moreno Carolina , Martins Diana , Oliveira Diana , Ventura Mara , Cunha Nelson , Marques Bernardo , Catarino Diana , Fadiga Lucia , Carrilho Francisco

Introduction: Pheochromocytoma (Pheo) and paragangliomas (PGL) are rare catecholamine-producing tumors.Near 35% of patients have disease-causing germline mutations.10% are malignant although the malignancy rate differs accordingly to the genetic background.Purpose: This study aims to characterize the sample of patients followed on a tertiary Portuguese Center and associate the presence of genetic mutation with clinical presentation.<p class="abstext"...

ea0049gp35 | Bone & Calcium Homeostasis 1 | ECE2017

Aldosterone and parathyroid hormone – is there a connection?

Ventura Mara , Melo Miguel , Oliveira Diana , Martins Diana , Lages Adriana , Cunha Nelson , Carrilho Francisco

Introduction: Recent studies seem to support a bidirectional positive interaction between aldosterone and parathyroid hormone (PTH). Understanding the normal physiological relationship between renin-angiotensin-aldosterone system (RAAS) and PTH is of clinical interest because their inappropriate activity may negatively impact cardiovascular and skeletal health.Objective: To evaluate the presence of an interaction between aldosterone and PTH in a cohort o...

ea0049ep61 | Adrenal cortex (to include Cushing's) | ECE2017

Autoimmune Addison disease – data from long-term follow-up of patients from a tertiary hospital’s Endocrinology Department

Oliveira Diana , Paiva Isabel , Lages Adriana , Martins Diana , Ventura Mara , Cunha Nelson , Paiva Sandra , Carrilho Francisco

Introduction: Autoimmune Addison disease requires lifelong glucocorticoid and mineralocorticoid replacement. Optimal therapy is not standardized and must balance adequate hormone substitution with prevention of treatment-related complications.Objective: Assessment of patients followed at our department: epidemiology, associated conditions, treatment, cumulative hydrocortisone dose and comorbidities.Methods: Review of clinical recor...

ea0049ep922 | Paediatric endocrinology | ECE2017

Endocrine manifestations of multisystem Langerhans cell histiocytosis

Oliveira Diana , Napoli Flavia , Bertelli Enrica , Maggioni Alessandra , Paiva Sandra , Carrilho Francisco , Iorgi Natascia Di

Introduction: Multisystem Langerhans cell histiocytosis (LCH) is a rare heterogeneous disorder caused by accumulation in multiple organs of dendritic cells phenotypically similar to cutaneous Langerhans cells. Pituitary involvement is present in about 25% of cases, and central diabetes insipidus is the most common deficit in that setting. Panhypopituitarism is rare, but hypothalamic-pituitary dysfunction is amongst the most frequent long-term complications of the disease.<...

ea0037gp.22.03 | Pituitary–Therapy of Cushing's disease | ECE2015

Impact of preoperative magnetic resonance in surgical care of patients with Cushing's disease

Guelho Daniela , Martins Diana , Paiva Isabel , Cardoso Luis , Vicente Nuno , Oliveira Diana , Balsa Margarida , Carrilho Francisco

Introduction: Cushing’s disease (CD) is a rare disorder caused by an ACTH-secreting pituitary adenoma. Transsphenoidal surgery (TSS) is the recommended first-line treatment. However, an equivocal or even normal preoperative MRI can preclude the surgical management and the outcome of these patients.Objectives: Evaluate the relationship between preoperative MRI and TSS efficacy in patients with CD.Methods: Retrospective cohort s...

ea0037ep512 | Diabetes (complications &amp; therapy) | ECE2015

Continuous subcutaneous insulin infusion decreases hypoglycaemia during nighttime

Vicente Nuno , Cardoso Luis , Baptista Carla , Barros Luisa , Guelho Daniela , Oliveira Diana , Martins Diana , Carrilho Francisco

Introduction: Continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) are forms of intensified insulin therapy and the most used regimens for type 1 diabetes (T1D). Owing to its continuous basal output, hypoglycaemic events tend to be rarer with CSII. Our goal was to evaluate the differences in nocturnal hypoglycemia between these two treatment strategies.Methods: Retrospective analysis of 61 patients who had performed continu...

ea0049ep203 | Neuroendocrinology | ECE2017

Quality of life in patients with neuroendocrine tumors treated with 177Lu-[DOTA0,Tyr3]-octreotate: a Single Tertiary Care Portuguese Center Experience

Lages Adriana , Moreira Helder , Costa Gracinda , Oliveira Patricia , Oliveira Diana , Martins Diana , Ventura Mara , Cunha Nelson , Carrilho Francisco

Introduction and purpose: 177Lu-[DOTA0,Tyr3]octreotate (177Lu-DOTA-TATE) is a radiopharmaceutical frequently used in peptide receptor radionuclide therapy (PRRT), which is a promising treatment modality in patients with metastasized neuroendocrine tumors (NETs). We purpose to evaluate the quality of life (QoL) in patients with somatostatin receptor positive inoperable or metastatic NETs throughout the three cycle’s (with three months intervals) proto...

ea0049ep1009 | Pituitary - Clinical | ECE2017

Aggressive pituitary tumors: a tertiary center experience

Lages Adriana , Paiva Isabel , Gomes Leonor , Oliveira Patricia , Belo Francisco , Oliveira Diana , Martins Diana , Ventura Mara , Cunha Nelson , Carrilho Francisco

Background: Pituitary adenomas (PA) are common intracranial tumors that are mainly considered benign. A small group of patients exhibit clinically aggressive behavior sometimes unrelated to the histopathological or radiological features.Methods: Twelve patients were selected harboring a PA with clinical features of aggressiveness. All the patients underwent pre and postoperative endocrinologic/neuroradiologic evaluation.Results: 10...